Nightingale Health Eo Stock Fundamentals

7XE Stock  EUR 3.00  0.12  4.17%   
NIGHTINGALE HEALTH EO fundamentals help investors to digest information that contributes to NIGHTINGALE HEALTH's financial success or failures. It also enables traders to predict the movement of NIGHTINGALE Stock. The fundamental analysis module provides a way to measure NIGHTINGALE HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NIGHTINGALE HEALTH stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

NIGHTINGALE HEALTH EO Company Shares Owned By Insiders Analysis

NIGHTINGALE HEALTH's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

 = 

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Current NIGHTINGALE HEALTH Shares Owned By Insiders

    
  50.45 %  
Most of NIGHTINGALE HEALTH's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NIGHTINGALE HEALTH EO is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition

Based on the latest financial disclosure, 50% of NIGHTINGALE HEALTH EO are shares owned by insiders. This is 232.35% higher than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The shares owned by insiders for all Germany stocks is notably lower than that of the firm.

NIGHTINGALE HEALTH Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining NIGHTINGALE HEALTH's current stock value. Our valuation model uses many indicators to compare NIGHTINGALE HEALTH value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NIGHTINGALE HEALTH competition to find correlations between indicators driving NIGHTINGALE HEALTH's intrinsic value. More Info.
NIGHTINGALE HEALTH EO is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NIGHTINGALE HEALTH's earnings, one of the primary drivers of an investment's value.

NIGHTINGALE Shares Owned By Insiders Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NIGHTINGALE HEALTH's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NIGHTINGALE HEALTH could also be used in its relative valuation, which is a method of valuing NIGHTINGALE HEALTH by comparing valuation metrics of similar companies.
NIGHTINGALE HEALTH is currently under evaluation in shares owned by insiders category among its peers.

NIGHTINGALE Fundamentals

About NIGHTINGALE HEALTH Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze NIGHTINGALE HEALTH EO's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NIGHTINGALE HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NIGHTINGALE HEALTH EO based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Nightingale Health Ltd. offers a health data platform that detects disease risks. The company was founded in 2002 and is based in Helsinki, Finland. NIGHTINGALE HEALTH is traded on Frankfurt Stock Exchange in Germany.

Currently Active Assets on Macroaxis

Other Information on Investing in NIGHTINGALE Stock

NIGHTINGALE HEALTH financial ratios help investors to determine whether NIGHTINGALE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NIGHTINGALE with respect to the benefits of owning NIGHTINGALE HEALTH security.